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Diseases attributable to nontuberculous mycobacteria (NTM) are on the rise, and
NTM is responsible for an increasing proportion of mycobacterial diseases in
many developed countries.
1,2 In South Korea, the number of NTM isolates
increased from 448 in 1992 to 1,737 in 2002, while the total number of myco-
bacterial colonies referred to the Korean Institute of Tuberculosis has decreased
from 18,970 to 5,181 in the same period.
3 NTM can cause lung disease in an
immunocompetent host as well as in an immunocompromised host such as an
acquired immune deficiency syndrome (AIDS) patient.
2 Decisions regarding the
diagnosis and treatment of NTM pulmonary disease can be problematic because
clinical findings, radiographic characteristics, and microbiological culture results
must be carefully considered to exclude other possible etiologies.
1-4
Most species of NTM are resistant to first-line anti-tuberculosis drugs, but they
do respond to newer macrolides such as azithromycin and clarithromycin. In the
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Mycobacterium abscessus (M. abscessus) is the second most common
nontuberculous mycobacteria (NTM) in South Korea. Nevertheless, the
diagnosis and treatment of M. abscessus lung disease can be problematic.
Surgical resection has been tried for patients with localized M. abscessus lung
disease refractory to medical treatment. Here, we report on a 25-year-old
woman with M. abscessus lung disease who had been diagnosed and treated
three times for pulmonary tuberculosis. She was initially diagnosed as having
M. intracellulare lung disease; however, M. abscessus was isolated after
several months of medication. She had multiple bronchiectatic and cavitary
lesions bilaterally, and M. abscessus was repeatedly isolated from her sputa
despite prolonged treatment with clarithromycin, ethambutol, moxifloxacin,
and amikacin. She improved only after sequential bilateral lung resection.
Based on the experience with this patient, we suggest that, if medical treatment
fails, surgical resection of a diseased lung should be considered even in
patients with bilateral lesions. 
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INTRODUCTIONcase of a rapidly growing mycobacterium such as Myco-
bacterium abscessus (M. abscessus), antimicrobial treatment
is further complicated by high levels of in vitro resistance.
Thus, injectable antimicrobial drugs and longer durations
of treatment are needed.
5 Despite the use of these poten-
tially toxic drugs, studies have reported treatment success
rates of only 56.3% and 55.6%.
6,7 In this context, surgical
resection has been tried for localized M. abscessus lung
disease.
1,8,9 In the present work, we report a case involving a
patient with M. abscessus lung disease, initially diagnosed
as having M. intracellulare, who improved with sequential
bilateral lung resection and anti-mycobacterial medications.
A 25-year-old woman arrived at our hospital citing fever
and chills for 2 days. She also complained of a productive
cough, night sweats, and general weakness for several
weeks. She had been treated as if she had pulmonary
tuberculosis (TB) three times previously, 17, 12, and 5
years earlier. Although the results from the mycobacterial
studies of the first two episodes of TB were not available,
the anti-TB treatments for the first and second episodes of
TB had each continued for 6 months, and she reported that
she took every medication as scheduled. Five years ago,
she was diagnosed as having recurrent pulmonary TB
based on an acid-fast staining of sputum. A mycobacterial
culture was not performed. Treatment with isoniazid,
rifampicin, ethambutol, and pyrazinamide was again
started. However, the regimen was transiently changed to
non-hepatotoxic drugs, including ethambutol, streptomy-
cin, and cycloserine. She experienced several adverse drug
effects: pancytopenia of rifampicin, ototoxicity of strepto-
mycin, and neurotoxicity of cycloserine.
On admission to our hospital, her vitals were as follows:
blood pressure, 110/50 mmHg; body temperature, 38.4˚C;
pulse rate, 126 bpm; and respiration rate, 20 breaths per
minute. A physical examination revealed crackles in both
lower lobes and inspiratory wheezing in the right middle
lobe and the left upper lobe, and there was no scarring
indicating a BCG vaccination on either arm. A chest roent-
genogram showed air space consolidation in both lower
lung zones with nodules and a right middle lobe collapse.
A computerized tomography (CT) scan of the chest revealed
bronchiectasis with a collapse of the right middle lobe and
air space consolidation with cavity formation in the left
lower lobe. In addition, in the right upper lobe and both
lower lobes, there was branching linear opacity, revealing
bronchogenic spread (Fig. 1). Laboratory findings included
a white blood cell count of 20,500 cells/mm
3 (segment
form, 83.7%), hemoglobin of 11.6 g/dL, and platelet cell
count of 241,000 cells/mm
3. Arterial blood gas analysis
performed while breathing without oxygen supplements
revealed a pH of 7.39, partial pressure of oxygen of 82.2
mmHg, partial pressure of carbon dioxide of 37.8 mmHg,
and oxygen saturation of 95.9%. Hepatic function was
normal, except for a mildly elevated aspartate aminotrans-
ferase (AST) level of 62 U/L. Renal function was normal,
and an human immunodeficiency virus (HIV) test was
negative. Acid-fast staining of her sputa revealed numerous
bacilli (1-9/10 HPF). 
Assuming that she had drug-resistant pulmonary TB, we
started a regimen that included isoniazid, ethambutol,
levofloxacin, prothionamide, pyrazinamide, and p-amino-
salicylic acid. We did not use rifampicin or aminoglyco-
side because of previous adverse effects. P-aminosalicylic
acid was also discontinued within 2 weeks due to abdominal
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Fig. 1.High-resolution computed tomography (HRCT) on admission showed the collapse with bronchiectasis of right middle lobe, cavitary lesion of
left lower lobe, and multiple branching linear opacity on both lower lobes (A and B). Follow-up HRCT performed one year following the medical
treatment revealed minimal improvement (C and D). No newly developed lesion was observed on HRCT taken eight months after bilateral lung
resection (E and F).
A B C
D E Fpain. Colonies of mycobacteria were identified in her sputa
after 40 days of culture in the Lowenstein-Jensen medium.
These bacilli were proved to be NTM, instead of M. tuber-
culosis complex, by a Gen-Probe test (Gen-Probe Inc., San
Diego, CA, USA). These mycobacteria were identified as
M. intracellulare by a previously reported polymerase
chain reaction-restriction fragment length polymorphism
(PCR-RFLP) method using cultured mycobacterial colonies
at the Korean Institute of Tuberculosis.
10 Under the diag-
nosis of M. intracellulare lung disease, the regimen was
changed to clarithromycin, ethambutol, and moxifloxacin.
Despite the regular intake of medication, her symptoms
did not improve, and the results of smears for acid-fast
bacilli were repeatedly positive (1-9/100 HPF). After 8
months of medication, M. abscessus was isolated instead
of M. intracellulare (Table 1). A chest CT performed 1
year after the treatment began revealed minimal improve-
ment (Fig. 1). Amikacin was added to the regimen after
careful evaluation of her hearing function. However, she
refused to try cefoxitin and imipenem because of possible
leukopenia and high cost. We performed a bronchoscopic
lavage to identify causative mycobacteria, and M. abscessus
was isolated from the cultures of lavaged fluid from the
right middle and left lower lobes.
Considering the poor symptomatic response to anti-
mycobacterial medications and the persistence of a cavi-
tary lesion, we decided to conduct a surgical resection. She
underwent a video-assisted thoracoscopic right middle
lobe lobectomy, right lower lobe wedge resection, and
right upper lobe wedge resection. She was discharged 6
days after the operation without postoperative complication.
On the second operation, which was conducted 1 month
later, a video-assisted thoracoscopic left lower lobe basal
segmentectomy and left upper lobe wedge resection were
performed. She was discharged 11 days after the operation
without postoperative complication. After the second
operation, negative sputum conversion was achieved. At
11 months after the operation, the results of the smears for
acid-fast bacilli were negative, and the amount of sputum
had decreased. She was being kept on chemotherapy
regimens with clarithromycin, ethambutol, and moxifloxa-
cin without complaining of any respiratory symptoms
(Table 1). Amikacin was discontinued after 12 months
because of increasing tinnitus. A CT of the chest performed
9 months after the second operation revealed no new
lesions (Fig. 1). 
Approximately 40% of patients with M. abscessus lung
disease have an underlying medical condition, such as
previous mycobacterial infections, cystic fibrosis, lipoid
pneumonia, lung transplantation, achalasia, or other
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Table 1.Sequential Results of Acid Fast Smear, Mycobacterial Culture, and Identification of Sputa or Lavaged Fluid
Examination
Specimen
Bacteriologic results
Treatment
date AFB* Culture* Identification
Aug. 2003 Sputum ++ 3+ M. intracellulare
Isoniazid, ethambutol, levofloxacin, prothionamide, 
pyrazinamide, p-aminosalicylic acid were started
Oct. 2003 Sputum - 3+ M. intracellulare
Clarithromycin, ethambutol, moxifloxacin were 
started as a new regimen
Dec. 2003 Sputum ++ - - Continued
Jan. 2004 Sputum - 1+ M. abscessus Amikacin was added on May 2004
Dec. 2004 Sputum - 2+ M. abscessus Continued
Jan. 2005 Lavaged fluid - 3+ M. abscessus
� Continued
Mar. 2005 RML lobectomy, RUL and RLL wedge resection
Apr. 2005 Sputum - 2+ M. abscessus
Apr. 2005 LUL wedge resection, LLL basal segmentectomy
Jun. 2005 Sputum - - - Same regimen was continued
Jul. 2005 Amikacin was discontinued
Nov. 2005 Sputum - - - Continued
Jan. 2006 Sputum - - - Continued
Feb. 2006 Sputum - - - Continued
RML, right middle lobe; RUL, right upper lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.
*Quantitation scale for Acid-Fast Bacillus smears and mycobacterial growth on agar plates followed diagnostic standards of American Thoracic Society.
13
�M. abscessuswas isolated from lavaged fluids right middle lobe and left lower lobe.
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conditions associated with recurrent vomiting.
4,5,8 These
patients often develop the disease at a younger age com-
pared with patients without an underlying illness. In patients
without associated medical conditions, the lung disease
progresses very slowly, and the chest radiograph usually
shows multilobar, patchy, reticulonodular or mixed inter-
stitial-alveolar infiltrates with an upper lobe predominance.
1
This patient was initially diagnosed as having M. intra-
cellulare pulmonary disease; however, M. abscessus was
isolated instead after the 8-month anti-mycobacterial treat-
ment. Mycobacterium abscessus likely caused the patient’s
lung disease because it was isolated from the lavaged fluid
from both lungs. In fact, alternative isolations of M. abs-
cessus and M. intracellulare have been reported to occur in
as many as 15% of patients with M. avium complex pul-
monary diseases and 31% of patients with M. abscessus
pulmonary disease.
8,11 Clinicians should carefully decide
which organism needs to be the target for treatment based
on serial isolations of NTM. 
The reported success rate of medical treatment in patients
with M. abscessus pulmonary disease has been low.
Griffith, et al.
8 reported that only 10 of the 119 patients with
M. abscessus were cured. Among these 10 patients, seven
received antibiotic treatment followed by surgical resection
of localized lesions, whereas only three were successfully
treated with antibiotics alone.
8 After the introduction of
macrolides, the prognosis of medical treatment in patients
with M. abscessus improved. In two Korean case series,
nine out of 16 patients and five out of nine patients with M.
abscessus were cured with medical treatment alone.
6,7
Although surgical resection for localized mycobacterial
disease can be associated with significant morbidity and
mortality
12 and the history of a underlying previous lung
disease can limit the surgical approach,
1 surgical resection
can be used in select patients with localized M. abscessus
lung disease. As far as we know, the patient in this report
was the first case to undergo bilateral sequential lung
resection for the treatment of M. abscessus lung disease.
The fact that sputum conversion was obtained only after
the second resection underscores the necessity for the
bilateral resection in this patient. Based on our experience
with this patient, we suggest that, if medical treatment
fails, resection of a diseased lobe should be considered
even in patients with bilateral lesions.  
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